News

MF Central is a unified digital platform designed to simplify mutual fund management for investors in India. It was launched in 2021 as a collaboration between CAMS and KFintech, following ...
Kotak Mahindra Mutual Fund acquired a 6.6% stake in Ami Organics for approximately Rs 301 crore through open market transactions, while Ami Organics' promoters divested an equivalent stake ...
Nippon India Mutual Fund has launched a new fund offer (NFO) on BSE Sensex Next 30 Index Fund. The passive fund will mirror the BSE Sensex Next 30 Index. The NFO opens for subscription on Wednesday.
He is Simon Mustard, who presented his credentials to President of Barbados The Most Honourable Dame Sandra Mason at State House today. Mustard, who succeeds Scott Furssedonn-Wood, expressed his ...
As of October 17, 2024, data cut-off, lacutamab demonstrated compelling and sustained clinical activity in heavily pretreated patients, with a global ORR of 42.9% for SS and 19.6% for MF.
Long term follow-up data from the TELLOMAK Phase 2 trial in Sézary syndrome (SS) and mycosis fungoides (MF) will be presented at the ASCO Annual Meeting 2025. Long-term follow-up data from ...
at Edelweiss MF. This fund excludes traditional IT giants (TCS, Infosys) entirely — allocating 100 percent to companies that are direct enablers or beneficiaries of the internet economy.
In the eye-catching ensemble, she channelled vintage charm. She is dressed in a striking mustard yellow co-ord set that highlights her figure with a high-waisted pencil skirt and a structured ...
The French biotech has been evaluating lacutamab in the Tellomak trial of 63 patients with Sézary syndrome (SS), a rare form of the blood cancer, and 107 patients with mycosis fungoides (MF), the ...
All patients had a diagnosis compatible with MF, as confirmed by clinical evaluation, histopathology, immuno-histochemistry and molecular biology. Major eligibility criteria for this study were ...
KIR3DL2 is expressed in up to 50% of patients with mycosis fungoides and peripheral T-cell lymphoma (PTCL). It has a restricted expression on normal tissues. Lacutamab has been granted European ...